ARK Genomic Revolution ETF
ARKG
3 hedge funds and large institutions have $821K invested in ARK Genomic Revolution ETF in 2015 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and closing their positions.
50% more funds holding
Funds holding: 2 → 3 (+1)
32% more capital invested
Capital invested by funds: $623K → $821K (+$198K)
1.08% more ownership
Funds ownership: 7.71% → 8.8% (+1.1%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$187K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$3.76K |
| 3 |
Wells Fargo
San Francisco,
California
|
+$1.16K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Jane Street
New York
| $807K | +$187K | +8,037 | +30% |
|
|
2
UBS Group
Zurich,
Switzerland
| $13K | +$3.76K | +162 | +41% |
|
|
3
Wells Fargo
San Francisco,
California
| $1K | +$1.16K | +50 | New |
|
ARKG Hedge Fund Activity: Q2 2015 in Review
3 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in ARK Genomic Revolution ETF (ARKG) for Q2 2015, worth a combined $821K — up 32% from $623K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new ARKG positions and 0 closed out — a net gain of 1 holder — while 2 added to existing stakes and 0 trimmed.
The largest buyer was Jane Street, adding an estimated $187K.
- 3 institutional investors held ARK Genomic Revolution ETF (ARKG) as of Q2 2015, up from 2 in Q1 2015.
- Funds reported $821K of ARK Genomic Revolution ETF stock for Q2 2015, up 32% quarter-over-quarter.
- 1 fund opened new ARK Genomic Revolution ETF positions in Q2 2015 and 0 closed out, a net change of +1 holder.
- The largest ARK Genomic Revolution ETF buyer in Q2 2015 was Jane Street, an estimated $187K added.
Based on aggregated 13F filings for Q2 2015.